~~<i id='B2C283205F'><strike id='B2C283205F'><tt id='B2C283205F'><pre id='B2C283205F'></pre></tt></strike></i>~~

Home» knowledge» explore

explore

author：hotspot 2025-08-22 15:41:40 Page View：784

HHS 2020 — PhRMA is suing the Biden administration over its new Medicare drug price negotiation program. Graeme Sloan/Sipa USA

WASHINGTON — After losing the drug pricing fight on Capitol Hill, PhRMA is taking its battle to the courts.

The pharmaceutical industry’s biggest lobbying group on Wednesday filed a long-expected lawsuit challenging Democrats’ drug pricing law that allowed Medicare to start negotiating prices for certain medicines.

PhRMA joins a growing club of companies and trades challenging the law. Merck, Bristol Myers Squibb, and the Chamber of Commerce have already filed similar suits in different courts.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Democrats decry new health bill for going easy on private equity
Next article： Activists slam private health insurers over coverage restrictions

Wikipedia

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Duchennemusculardystrophyhistopathology.Dr.EdwinP.Ewing,Jr./CDCWhenIwasdiagnosedwithDuchennemuscular

Anthony Fauci pushes back on GOP claims during Covid hearing

AnthonyFauci,theformerheadoftheNationalInstituteofAllergyandInfectiousDiseases,testifiedbeforeaHouse

Psychedelics group wrestles with new pharma identity

OliviaGoldhill/STATDENVER—Hecouldhavebeenarockstar,areligiousicon,thewayecstaticapplausefromthousand

FTC loses bid to block Novant's North Carolina hospital merger

AdobeAfederaljudgeorderedWednesdaythatNovantHealthcanmoveforwardwithitsplantobuytwoNorthCarolinahosp